市场调查报告书
商品编码
1469824
全球口腔睡眠呼吸中止装置市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Oral Sleep Apnea Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
预计到 2032 年,全球口腔睡眠呼吸中止装置市场的市场规模将从 2023 年的 8.5115 亿美元达到近 16.0339 亿美元,2024-2032 年研究期间的复合年增长率为 7.29%。
口腔睡眠呼吸中止症装置或下颚前移装置 (MAD) 或牙齿矫正器是客製化的口腔装置,用于治疗阻塞性睡眠呼吸中止症 (OSA) 和打鼾。这些装置在睡眠期间佩戴,可将下颚和舌头重新定位向前,从而防止气道塌陷并改善气流,从而缓解睡眠呼吸障碍的症状。对于患有轻度至中度 OSA 的个体,口腔睡眠呼吸中止症装置可以取代持续性正压呼吸器 (CPAP) 治疗。
睡眠呼吸中止症是一种以睡眠期间呼吸中止症为特征的常见睡眠障碍,其盛行率不断上升,导致人们对该疾病的认识和诊断不断提高,从而推动了对口腔睡眠呼吸中止装置等有效治疗方案的需求。这些设备,包括下颚前移装置 (MAD) 和舌头固定装置 (TRD),透过调整下颚或舌头的位置来在睡眠期间保持气道开放,从而减轻睡眠呼吸中止症状的严重程度并提高整体睡眠品质。此外,连续呼吸道正压通气(CPAP) 治疗被认为是睡眠呼吸中止症的基准治疗方法,人们越来越倾向于选择无创且患者友好的治疗替代方案,这激发了那些发现CPAP 面罩不舒服或笨重的患者对口腔睡眠呼吸中止装置的兴趣。此外,牙科技术、材料科学和 3D 列印技术的进步催生了客製化和可调节的口腔睡眠呼吸中止装置,这些装置可提供更高的舒适度、耐用性和功效,推动市场创新和差异化。
此外,睡眠专家、牙医和製造商之间不断加强合作,以提高对睡眠呼吸中止症的认识、改进诊断和优化睡眠呼吸中止症的治疗方案,透过扩大口腔睡眠呼吸中止症设备的使用范围和推广睡眠障碍管理的多学科方法,促进了市场成长。最后,COVID-19 大流行对生活方式改变、压力水平和睡眠模式中断的影响提高了人们对睡眠健康的认识以及解决睡眠相关问题的重要性,从而推动了市场对口腔睡眠呼吸中止装置作为全面睡眠一部分的需求无序的管理策略,进一步推动了市场的扩张。然而,对设备功效、患者依从性以及替代治疗选择的竞争的担忧可能会挑战未来几年的市场成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球口腔睡眠呼吸中止症设备市场的各个细分市场进行了包容性评估。口腔睡眠呼吸中止症产业的成长和趋势为这项研究提供了整体方法。
口腔睡眠呼吸中止装置市场报告的这一部分提供了国家和区域层级细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲口腔睡眠呼吸中止设备市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。口腔睡眠呼吸中止设备市场的主要参与者包括 Vendor Landscape、Respironics(Koninklijke Philips NV 的子公司)、Fisher & Paykel Healthcare Limited、Curative Medical, Inc.、React Health(Invacare Corporation 的呼吸产品线)、Somnetics International、 Inc.、BMC Medical Co., Ltd.、Natus Medical Incorporated、SOMNOmedics GmbH、Compumedics、Itamar Medical Ltd.、Nihon Kohden Corporation。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Oral Sleep Apnea Devices Market is presumed to reach the market size of nearly USD 1603.39 Million by 2032 from USD 851.15 Million in 2023 with a CAGR of 7.29% under the study period 2024 - 2032.
Oral sleep apnea devices, or mandibular advancement devices (MADs) or dental appliances, are custom-fitted oral devices prescribed to treat obstructive sleep apnea (OSA) and snoring. These devices are worn during sleep to reposition the lower jaw and tongue forward, thus preventing airway collapse and improving airflow to alleviate symptoms of sleep-disordered breathing. For individuals experiencing mild to moderate OSA, oral sleep apnea devices offer a substitute for continuous positive airway pressure (CPAP) therapy.
The increasing prevalence of sleep apnea, a common sleep disorder featured by pauses in breathing during sleep, has led to growing awareness and diagnosis of the condition, driving demand for effective treatment options such as oral sleep apnea devices. These devices, including mandibular advancement devices (MADs) and tongue retaining devices (TRDs), work by adjusting the position of the jaw or tongue to maintain an open airway during sleep, lessening the severity of sleep apnea symptoms and enhancing overall sleep quality. Additionally, the rising preference for non-invasive and patient-friendly treatment alternatives to continuous positive airway pressure (CPAP) therapy, considered the benchmark treatment for sleep apnea, has fueled interest in oral sleep apnea devices among patients who find CPAP masks uncomfortable or cumbersome, driving market adoption. Moreover, advancements in dental technology, materials science, and 3D printing techniques have led to custom-fit and adjustable oral sleep apnea devices that offer improved comfort, durability, and efficacy, driving market innovation and differentiation.
Furthermore, the growing collaboration between sleep specialists, dentists, and manufacturers to raise awareness, improve diagnosis, and optimize treatment protocols for sleep apnea has contributed to market growth by expanding access to oral sleep apnea devices and promoting multidisciplinary approaches to sleep disorder management. Lastly, the impact of the COVID-19 pandemic on lifestyle changes, stress levels, and disrupted sleep patterns has heightened awareness of sleep health and the importance of addressing sleep-related issues, driving market demand for oral sleep apnea devices as part of comprehensive sleep disorder management strategies, further fuelling market expansion. However, concerns regarding device efficacy, patient compliance, and competition from alternative treatment options may challenge the market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral sleep apnea devices. The growth and trends of oral sleep apnea devices industry provide a holistic approach to this study.
This section of the oral sleep apnea devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Oral Sleep Apnea Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oral Sleep Apnea Devices market include Vendor Landscape, Respironics (a subsidiary of Koninklijke Philips N.V.), Fisher & Paykel Healthcare Limited, Curative Medical, Inc., React Health (Respiratory Product Line from Invacare Corporation), Somnetics International, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, SOMNOmedics GmbH, Compumedics, Itamar Medical Ltd., Nihon Kohden Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.